It has been observed that acquisition of chemoresistance correlated unexpectedly with increased expression and nuclear accumulation of FOXO3a in leukemic cells (Hui et al., 2008b) and breast cancer cells (Chen et al., 2010). This evidence concerns the gene FOXO3 and breast carcinoma.